Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Post by stockfyon Aug 03, 2021 8:48am
714 Views
Post# 33641494

VMD's Net Cash Position goes UP in Q2 versus Q1 2021

VMD's Net Cash Position goes UP in Q2 versus Q1 2021VMD's strong Q2 2021 and pristine balance sheet for another quarter in a row hurt "besttobe" alias and his buddies (the usual suspects) who have been twisting the truth or have been posting blatant lies about VMD over the last months.

In my previous comment, I posted facts about VMD's core revenue YoY growth, significant gross profit margin expansion (64% in Q2 2021 versus 60% in Q2 2020), strong profitability, strong positive operating cash flow and strong positive free cash flow for another quarter in a row.

On top of this, thanks to its strong positive free cash flow in Q2 2021, VMD maintained a pristine balance sheet.

Actually, the balance sheet in Q2 2021 is stronger than in Q1 2021 because VMD reduced its debt sequentially, so VMD increased its net cash position on a sequential basis.

Specifically, VMD's negative net debt was $24.5 million in Q2 2021 versus $23.9 million in Q1 2021.

To say it differently, VMD's cash & cash equivalents in Q2 2021 exceed the interest-bearing debt by $24.5 million.

Thanks to this pristine balance sheet, VMD will continue implementing its growth strategy in the next months.

And this growth strategy includes both organic growth and inorganic growth through the acquisition of other smaller names, as mentioned many times by the CEO and COO in the previous Conference Call.



<< Previous
Bullboard Posts
Next >>